Desmopressin in treatment of nocturnal enuresis (bedwetting).

Inclusion Criteria:

• Treatment of primary nocturnal enuresis within an overall therapeutical concept, eg, in cases of failure of other non-medicinal therapies or with indication of a medicinal therapy caused by nocturnal ADH deficiency
• The patients and their parents have been informed about the study and have given their written consent for participation.

Exclusion Criteria:

• The prescription of Minirin® tablets / Minirin® orally disintegrating tablet (fast dissolving desmopressin) is contraindicated

Patients with primary nocturnal enuresis